Paper Details

  1. Home
  2. Paper Details

Clinical utility of oral hypoglycemic agents in the management of patients with noninsulin-dependent diabetes mellitus.

Author: LebovitzH E

Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Overview

Sulfonylurea drugs are effective in controlling glycemia in patients with noninsulin-dependent diabetes mellitus. Approximately 60-70% of patients respond initially, but 15-20% do not respond initially or lose their responsiveness over time.
Paper Details　
Original Abstract of the Article :
Clinical usage of the sulfonylurea drugs is based on experience in well-controlled long-term studies in large numbers of patients. The results of such studies indicate that approximately 60 to 70 percent of the patients with noninsulin-dependent diabetes mellitus of recent onset will respond initial...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/0002-9343(83)90259-0

データ提供：米国国立医学図書館（NLM）

Oral Hypoglycemic Agents in the Management of Noninsulin-Dependent Diabetes Mellitus

Diabetes, like a thirsty traveler in a scorching desert, requires careful management to maintain balance. This review explores the clinical utility of oral hypoglycemic agents, specifically sulfonylureas, in managing noninsulin-dependent diabetes mellitus (NIDDM). Researchers summarize the effectiveness of these medications, highlighting their ability to control blood sugar levels in many patients with NIDDM. They also discuss factors that influence the success of sulfonylurea therapy, emphasizing the need for individualized treatment plans tailored to the unique needs of each patient.

Navigating the Desert of Diabetes Management

This review, like a guide through the vast desert of diabetes management, provides valuable insights into the use of oral hypoglycemic agents. It highlights the effectiveness of sulfonylureas in controlling blood sugar levels for many individuals with NIDDM, emphasizing the importance of individualized care and careful patient monitoring. It's a reminder that the journey through the desert of diabetes management requires a personalized approach, with the right tools and resources to maintain balance and well-being.

Managing Blood Sugar Levels

Diabetes management is an ongoing process that requires careful attention to blood sugar levels. This review underscores the importance of finding the right treatment approach for each individual, ensuring optimal blood sugar control and minimizing the risk of complications associated with diabetes. It's a reminder that the desert of diabetes management can be navigated effectively with the right knowledge, support, and personalized care.

Dr.Camel's Conclusion

This review provides a comprehensive overview of the clinical utility of oral hypoglycemic agents in managing NIDDM. It's a reminder that the desert of diabetes management can be navigated effectively with the right tools, resources, and personalized approach, leading to improved health outcomes and a better quality of life for those living with this condition.

Date :
  1. Date Completed 1984-05-11
  2. Date Revised 2019-06-27
Further Info :

Pubmed ID

6369972

DOI: Digital Object Identifier

10.1016/0002-9343(83)90259-0

Related Literature

Article Analysis
・Side Effects of glipizide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.